Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gillard

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|February 23, 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancerShruti D Shah, Bryan M Gillard, Michelle M Wrobel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2016
GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical ModelsMojgan Shourideh, Gissou Azabdaftari, Kristopher Attwood, et al.
The British Journal of Dermatology|February 18, 2018
Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patientsM Gillard, D Anuset, H Maillard, et al.
American Journal of Clinical and Experimental Urology|January 7, 2022
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMichalis Mastri, Swathi Ramakrishnan, Shruti D Shah, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 19, 2025
Impact of Margins on Outcomes in HPV-Related Oropharyngeal Squamous Cell Carcinoma Treated With Surgery OnlyOmar A Karadaghy, Michael P Wu, Nathan Farrokhian, et al.
Oncotarget|December 22, 2017
Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 modelHayley C Affronti, Mark D Long, Spencer R Rosario, et al.
Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Discovery of orally bioavailable NK1 receptor antagonistsC Genicot, B Christophe, P Collart, et al.
Scientific Reports|January 8, 2025
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancerTatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|February 23, 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancerShruti D Shah, Bryan M Gillard, Michelle M Wrobel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2016
GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical ModelsMojgan Shourideh, Gissou Azabdaftari, Kristopher Attwood, et al.
The British Journal of Dermatology|February 18, 2018
Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patientsM Gillard, D Anuset, H Maillard, et al.
American Journal of Clinical and Experimental Urology|January 7, 2022
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMichalis Mastri, Swathi Ramakrishnan, Shruti D Shah, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 19, 2025
Impact of Margins on Outcomes in HPV-Related Oropharyngeal Squamous Cell Carcinoma Treated With Surgery OnlyOmar A Karadaghy, Michael P Wu, Nathan Farrokhian, et al.
Oncotarget|December 22, 2017
Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 modelHayley C Affronti, Mark D Long, Spencer R Rosario, et al.
Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Discovery of orally bioavailable NK1 receptor antagonistsC Genicot, B Christophe, P Collart, et al.
Scientific Reports|January 8, 2025
Inosine monophosphate dehydrogenase 2 (IMPDH2) modulates response to therapy and chemo-resistance in triple negative breast cancerTatiane da Silva Fernandes, Bryan M Gillard, Tao Dai, et al.
Iscience|November 29, 2023
Aryl hydrocarbon receptor is a tumor promoter in <i>MYCN</i>-amplified neuroblastoma cells through suppression of differentiationKanita A Chaudhry, Justine J Jacobi, Bryan M Gillard, et al.
Pageof 11